Variant report
Variant | nsv527885 |
---|---|
Chromosome Location | chr21:17758842-17759180 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1449522 | chr21:17758842-17758843 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs182395370 | chr21:17758843-17758844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187808535 | chr21:17758872-17758873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576394908 | chr21:17758875-17758876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17210086 | chr21:17758884-17758885 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs115835849 | chr21:17758887-17758888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140130123 | chr21:17758912-17758913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540787282 | chr21:17758939-17758940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149422817 | chr21:17758942-17758943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529911432 | chr21:17758952-17758953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549697911 | chr21:17758960-17758961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569622941 | chr21:17758988-17758989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117456327 | chr21:17758994-17758995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552153820 | chr21:17759021-17759022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192195561 | chr21:17759025-17759026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs240467 | chr21:17759097-17759098 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs545166566 | chr21:17759130-17759131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184972043 | chr21:17759138-17759139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189387792 | chr21:17759140-17759141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17307376 | chr21:17759162-17759163 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs116749801 | chr21:17759176-17759177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192142921 | chr21:17759178-17759179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2823769 | chr21:17759180-17759181 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Epilepsy | 20502679 | CNVD |
22q11.2 microdeletion syndrome | 19750312 | CNVD |
Breast cancer | 20409316 | CNVD |
Gastric cancer | 18160780 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:17735800-17767200 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr21:17742800-17760800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr21:17745200-17764000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr21:17751200-17760600 | Weak transcription | Ovary | ovary |
5 | chr21:17751600-17760800 | Weak transcription | Rectal Smooth Muscle | rectum |
6 | chr21:17752800-17763200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr21:17758600-17759400 | Enhancers | Fetal Lung | lung |
8 | chr21:17758800-17759200 | Enhancers | Brain Substantia Nigra | brain |
9 | chr21:17759000-17759200 | Enhancers | Fetal Heart | heart |